Position statement: global neuraminidase inhibitor susceptibility network

This publication has 24 references indexed in Scilit:

• Selection of Influenza Virus Mutants in Experimentally Infected Volunteers Treated with Oseltamivir
  The Journal of Infectious Diseases, 2001
• Resistance of influenza viruses to neuraminidase inhibitors — a review
  Antiviral Research, 2000
• Rapid Antiviral Effect of Inhaled Zanamivir in the Treatment of Naturally Occurring Influenza in Otherwise Healthy Adults
  The Journal of Infectious Diseases, 2000
• Low Incidence of Rimantadine Resistance in Field Isolates of Influenza A Viruses
  The Journal of Infectious Diseases, 1999
• Common Emergence of Amantadine‐ and Rimantadine‐Resistant Influenza A Viruses in Symptomatic Immunocompromised Adults
  Clinical Infectious Diseases, 1998
• Prolonged Shedding of Amantadine-Resistant Influenza A Viruses by Immunodeficient Patients: Detection by Polymerase Chain Reaction-Restriction Analysis
  The Journal of Infectious Diseases, 1995
• Influenza virus neuraminidase: Structure, antibodies, and inhibitors
  Protein Science, 1994
• 4-Guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid is a highly effective inhibitor both of the sialidase (neuraminidase) and of growth of a wide range of influenza A and B viruses in vitro
  Antimicrobial Agents and Chemotherapy, 1993
• Amantadine-resistant influenza A in a nursing facility
  Archives of internal medicine (1960), 1992
• Emergence and Apparent Transmission of Rimantadine-Resistant Influenza A Virus in Families
  New England Journal of Medicine, 1989